Table of contents for Competition law and patents : a follow-on innovation perspective in the biopharmaceutical industry / by Irina Haracoglou.

Bibliographic record and links to related information available from the Library of Congress catalog.

Note: Contents data are machine generated based on pre-publication provided by the publisher. Contents may have variations from the printed book or be incomplete or contain other coding.


Counter
Contents
Acknowledgements
Preface
List of Abbreviations
Table of Cases
Part I: The problem - Access as a necessary element of follow-on innovation?
1. Biopharmaceutical R&D: The increased importance of cumulative innovation and 
related concerns
Part II: The Patent Balance & Working Solutions in the Patent System
2. The patent system as a system of balancing
3. The Patent System and Some Potential Safety Nets
4. The Right to Health as an Interpretive Principle of Patent Law
PART III: Antitrust as a Complement to the Patent System
5. Unilateral conduct, IPRs and Competition Law: A Systems' Interaction
6. The Duty to Deal under Art. 82 EC
PART IV: A MORE INNOVATION SENSITIVE APPROACH TO THE 
INTERFACE OF COMPETITION LAW & PATENTS?
7. The Duty to Deal as Applied to Address Technology Access Problems in the 
Biopharmaceutical Industry
Bibliography
Index

Library of Congress Subject Headings for this publication:

Patent laws and legislation.
Pharmaceutical biotechnology -- Patents.
Pharmaceutical biotechnology -- Law and legislation.
Competition, Unfair.